Home › Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data
 

Keywords :   


Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data

2015-03-04 04:49:19| drugdiscoveryonline Home Page

DSG, Inc and Sirion Therapeutics collaborated in launching the industry’s first two pivotal Phase 3 studies using entirely electronic source data collection for the safety and efficacy of Difluprednate in the management of inflammation following ocular surgery

Tags: data source fully studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Forecast Discussion Number 9
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 19
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 9
More »